{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:04:59Z","timestamp":1790892299300,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,4,18]],"date-time":"2006-04-18T00:00:00Z","timestamp":1145318400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>With the increasing interest with botulinum toxin \u2013 A (BTX-A) application in the lower urinary tract, we investigated the BTX-A effects on the canine prostate and also in men with bladder outlet obstruction (BOO) due to benign prostatic hyperplasia (BPH).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Transperineal injection into the prostate using transrectal ultrasound (TRUS) was performed throughout the study. Saline with or without 100 U of BTX-A was injected into mongrel dogs prostate. One or 3 months later, the prostate was harvested for morphologic and apoptotic study. In addition, eight BPH patients refractory to \u03b1-blockers were treated with ultrasound guided intraprostatic injection of 200 U of BTX-A.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In the BTX-A treated dogs, atrophy and diffuse apoptosis was observed with H&amp;E stain and TUNEL stain at 1 and 3 months. Clinically, the mean prostate volume, symptom score, and quality of life index were significantly reduced by 18.8%, 73.1%, and 61.5% respectively. Maximal flow rate significantly increased by 72.0%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Intraprostatic BTX-A injection induces prostate apotosis in dogs and relieves BOO in humans. It is therefore a promising alternative treatment for refractory BOO due to BPH.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2490-6-12","type":"journal-article","created":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T15:45:03Z","timestamp":1145547903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Intraprostatic injection of botulinum toxin type- A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs"],"prefix":"10.1186","volume":"6","author":[{"given":"Yao-Chi","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Hsien","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hui","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B","family":"Chancellor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,4,18]]},"reference":[{"key":"67_CR1","first-page":"557","volume":"335","author":"PC Walsh","year":"1996","unstructured":"Walsh PC: Treatment of benign prostatic hyperplasia. N Engl J Med. 1996, 335: 557-563.","journal-title":"N Engl J Med"},{"key":"67_CR2","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1056\/NEJM198904273201705","volume":"320","author":"NP Roos","year":"1989","unstructured":"Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, Cohen MM, Ramsey E: Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med. 1989, 320: 1120-1124.","journal-title":"N Engl J Med"},{"key":"67_CR3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0022-5347(17)44991-3","volume":"136","author":"RC Bruskewitz","year":"1986","unstructured":"Bruskewitz RC, Larsen EH, Madsen P, Dorflinger T: 3-year follow-up of urinary symptoms after transurethral of the prostate. J Urol. 1986, 136: 613-615.","journal-title":"J Urol"},{"key":"67_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","volume":"170","author":"C Roehrborn","year":"2003","unstructured":"Roehrborn C, McConnell J, Barry M, Benaim E, Bruskewitz R, Blute M: AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol. 2003, 170: 530-547. 10.1097\/01.ju.0000078083.38675.79.","journal-title":"J Urol"},{"key":"67_CR5","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM199104253241707","volume":"324","author":"J Jankovic","year":"1991","unstructured":"Jankovic J, Brin MF: Therapeutic uses of botulinum toxin. N Engl J Med. 1991, 324: 1186-1194.","journal-title":"N Engl J Med"},{"key":"67_CR6","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/0306-4522(82)90056-2","volume":"7","author":"I MacKenzie","year":"1982","unstructured":"MacKenzie I, Burnstock G, Dolly JO: The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomi neuromuscular transmission. Neuroscience. 1982, 7: 997-1006. 10.1016\/0306-4522(82)90056-2.","journal-title":"Neuroscience"},{"key":"67_CR7","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","volume":"171","author":"CP Smith","year":"2004","unstructured":"Smith CP, Chancellor MB: Emerging Role of botulinum toxin in the treatment of voiding dysfunction. J Urol. 2004, 171: 2128-2137. 10.1097\/01.ju.0000127725.48479.89.","journal-title":"J Urol"},{"key":"67_CR8","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0022-5347(05)66438-5","volume":"165","author":"MW Phelan","year":"2001","unstructured":"Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP, Yoshimura N, Chancellor MB: Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol. 2001, 165: 1107-1110. 10.1097\/00005392-200104000-00011.","journal-title":"J Urol"},{"key":"67_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0090-4295(02)02541-4","volume":"61","author":"HC Kuo","year":"2003","unstructured":"Kuo HC: Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity. Urology. 2003, 61: 550-554. 10.1016\/S0090-4295(02)02541-4.","journal-title":"Urology"},{"key":"67_CR10","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1097\/01.ju.0000049202.56189.54","volume":"169","author":"CP Smith","year":"2003","unstructured":"Smith CP, Franks MF, McNeil BK, Ghosh R, deGroat WC, Chancellor MB, Somogyi GT: Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol. 2003, 169: 1896-1900. 10.1097\/01.ju.0000049202.56189.54.","journal-title":"J Urol"},{"key":"67_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/(SICI)1097-0045(19980915)37:1<44::AID-PROS7>3.0.CO;2-8","volume":"37","author":"R Doggweiler","year":"1998","unstructured":"Doggweiler R, Zermann DH, Ishigooka M, Schmidt RA: Botox induced prostatic involution. Prostate. 1998, 37: 44-50. 10.1002\/(SICI)1097-0045(19980915)37:1<44::AID-PROS7>3.0.CO;2-8.","journal-title":"Prostate"},{"key":"67_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0090-4295(03)00477-1","volume":"62","author":"G Maria","year":"2003","unstructured":"Maria G, Brisinda G, Civello IM, Bentivoglio AR, Sganga G, Albanese A: Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology. 2003, 62: 259-265. 10.1016\/S0090-4295(03)00477-1.","journal-title":"Urology"},{"key":"67_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.urology.2005.04.029","volume":"66","author":"YC Chuang","year":"2005","unstructured":"Chuang YC, Chiang PH, Huang CC, Yoshimura N, Chancellor MB: Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology. 2005, 66: 775-779. 10.1016\/j.urology.2005.04.029.","journal-title":"Urology"},{"key":"67_CR14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.urology.2004.10.077","volume":"65","author":"HC Kuo","year":"2005","unstructured":"Kuo HC: Prostate Botulinum toxin A injection- an alternative treatment for benign prostatic obstruction in poor surgical candidates. Urology. 2005, 65: 670-674. 10.1016\/j.urology.2004.10.077.","journal-title":"Urology"},{"key":"67_CR15","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/S0022-5347(01)66828-9","volume":"154","author":"ATL Lin","year":"1995","unstructured":"Lin ATL, Chen MT, Chiang H, Yang CH, Chang LS: Effect of orchiectomy on the alpha adrenergic contractile response of dog prostate. J Urol. 1995, 154: 1930-1933. 10.1016\/S0022-5347(01)66828-9.","journal-title":"J Urol"},{"key":"67_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0090-4295(99)00043-6","volume":"53","author":"DA Levy","year":"1999","unstructured":"Levy DA, Cromeens DM, Evans R, Stephens LC, von Eschenbach AC, Pisters LL: Transrectal ultrasound-guided intraprostatic injection of absolute ethanol with and without carmustine: a feasibility study in the canine model. Urology. 1999, 53: 1245-1251. 10.1016\/S0090-4295(99)00043-6.","journal-title":"Urology"},{"key":"67_CR17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0090-4295(02)02514-1","volume":"61","author":"P-H Chiang","year":"2003","unstructured":"Chiang P-H, Chuang Y-C, Huang C-C, Chiang C-P: Pilot study of transperineal injection of dehydrated ethanol in the treatment of prostatic obstruction. Urology. 2003, 61: 797-801. 10.1016\/S0090-4295(02)02514-1.","journal-title":"Urology"},{"key":"67_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.119.3.493","volume":"119","author":"Y Gavrieli","year":"1992","unstructured":"Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992, 119: 493-501. 10.1083\/jcb.119.3.493.","journal-title":"J Cell Biol"},{"key":"67_CR19","first-page":"553","volume-title":"Proceedings of the 2nd International Consultation on Benign Prostatic Hyperplasia (BPH) Paris","author":"A Cockett","year":"1994","unstructured":"Cockett A, Aso Y, Denis L: Prostate symptom score and quality of life assessment. Proceedings of the 2nd International Consultation on Benign Prostatic Hyperplasia (BPH) Paris. Edited by: Cockett ATK, Khoury S, Aso Y, et al. 1994, Jersey, Channel Island, Scientific Communication International, 553-555. June 27\u201330, 1993"},{"key":"67_CR20","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0022-5347(17)43594-4","volume":"138","author":"H Lepor","year":"1987","unstructured":"Lepor H, Baumann M, Shapiro E: Identification and characterization of alpha 1 adrenergic receptors in the canine prostate using [125I]-Heat. J Urol. 1987, 138: 1336-1339.","journal-title":"J Urol"},{"key":"67_CR21","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/sj.bjp.0703409","volume":"130","author":"WA Lau","year":"2000","unstructured":"Lau WA, Pennefather JN, Mitchelson FJ: Cholinergic facilitation of neurotransmission to the smooth muscle of the guinea-pig prostate gland. British J Pharmacology. 2000, 130: 1013-1020. 10.1038\/sj.bjp.0703409.","journal-title":"British J Pharmacology"},{"key":"67_CR22","first-page":"19","volume":"5","author":"YJ Niu","year":"2003","unstructured":"Niu YJ, Ma TX, Zhang J, Xu Y, Han RF, Sun G: Androgen and prostatic stroma. Asian J Androl. 2003, 5: 19-26.","journal-title":"Asian J Androl"},{"key":"67_CR23","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/S0022-5347(05)00318-6","volume":"173","author":"YC Chuang","year":"2006","unstructured":"Chuang YC, Huang CC, Kang HY, Chiang PH, de Miguel F, Yoshimura N, Chancellor MB: Novel action of Botulinum toxin on the stromal and epithelial components of prostate gland. J Urol. 2006, 173: 1158-1163. 10.1016\/S0022-5347(05)00318-6.","journal-title":"J Urol"},{"key":"67_CR24","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1097\/01.ju.0000033280.29453.72","volume":"169","author":"N Kyprianou","year":"2003","unstructured":"Kyprianou N: Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance. J Urol. 2003, 169: 1520-1525. 10.1097\/01.ju.0000033280.29453.72.","journal-title":"J Urol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2490-6-12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2490-6-12\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2490-6-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2490-6-12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T21:40:41Z","timestamp":1630446041000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/1471-2490-6-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,18]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["67"],"URL":"https:\/\/doi.org\/10.1186\/1471-2490-6-12","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,18]]},"assertion":[{"value":"6 December 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"12"}}